<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nefr</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology (Saint-Petersburg)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1561-6274</issn><issn pub-type="epub">2541-9439</issn><publisher><publisher-name>Pavlov First Saint-Petersburg State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24884/1561-6274-2019-23-4-112-118</article-id><article-id custom-type="elpub" pub-id-type="custom">nefr-1729</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ПРОГРАММА НЕПРЕРЫВНОГО ПОСЛЕДИПЛОМНОГО ОБРАЗОВАНИЯ ПО НЕФРОЛОГИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PROGRAM ON CONTINUOUS POSTGRADUATE EDUCATION ON NEPHROLOGY</subject></subj-group></article-categories><title-group><article-title>Современные биомаркеры повреждения почек в педиатрии</article-title><trans-title-group xml:lang="en"><trans-title>Modern biomarkers of renal damage in pediatrics</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0581-7285</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Смирнова</surname><given-names>Н. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Smirnowa</surname><given-names>N. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Смирнова Наталия Николаевна - докор медицинских наук, профессор, кафедра педиатрии, заведующая кафедрой.</p><p>197022, Санкт-Петербург, ул. Л. Толстого, д. 6-8, Тел.: +7(921)429-49-31</p></bio><bio xml:lang="en"><p>Natalia Smirnowa - PhD, DMedSci, Prof., Nephrology Laboratory of the head of pediatric department.</p><p>197022, St-Petersburg , L.Tolstoy st., 17, build. 54</p></bio><email xlink:type="simple">nephro-uro-kids@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Галкина</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Galkina</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Галкина Ольга Владимировна - кандидат биологических наук, лаборатория биохимического гомеостаза, заведующая лабораторией.</p><p>197022, Санкт-Петербург, ул. Л. Толстого, д. 6-8, Тел.: +7 (812) 338-69-31</p></bio><bio xml:lang="en"><p>Olga Galkina - PhD, Nephrology Laboratory of Biochemical Homeostasis, head.</p><p>197022, St-Petersburg , L.Tolstoy st., 17, build. 54, 7(812)338-69-31</p></bio><email xlink:type="simple">ovgalkina@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0992-1709</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Новикова</surname><given-names>В. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Novikova</surname><given-names>V. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Новикова Валерия Павловна - докор медицинских наук, профессор, кафедры детских болезней педиатрического факультета ПСПбГМУ им. акад. И.П. Павлова, лаборатория медико-социальных проблем в педиатрии, заведующая лабораторией СПбГПМУ.</p><p>197022, Санкт-Петербург, ул. Л. Толстого, д. 6-8; Санкт-Петербург, ул. Литовская, д. 2, Тел. +7(911)738-63-50</p></bio><bio xml:lang="en"><p>Valeria Novikova - MD, PhD, DMedSci, Prof. children diseases department First Pavlov St.-Petersburg SMU; laboratory of medical and social problems in pediatrics the head SPSPMU.</p><p>197022, St-Petersburg , L.Tolstoy st., 6-8; Saint Petersburg, Litovskaja str.,2, Phone +7(911)738-63-50</p></bio><email xlink:type="simple">novikova-vp@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5412-1412</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Прокопьева</surname><given-names>Н. Э.</given-names></name><name name-style="western" xml:lang="en"><surname>Prokopyeva</surname><given-names>N. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Прокопьева Наталья Эдуардовна - лаборатория медико-социальных проблем в педиатрии, врач-исследователь.</p><p>194100, Санкт-Петербург, ул. Литовская, д. 2</p></bio><bio xml:lang="en"><p>Natalja Prokopjeva - MD. laboratory of medical and social problems in pediatrics, physician-researcher of.</p><p>194100, Saint Petersburg Litovskaja str., 2</p></bio><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П.Павлова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>First Pavlov Saint-Petersburg State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П.Павлова; Санкт-Петербургский государственный педиатрический медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>First Pavlov Saint-Petersburg State Medical University; Saint-Petersburg State Pediatric Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Санкт-Петербургский государственный педиатрический медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Saint-Petersburg State Pediatric Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>23</day><month>06</month><year>2019</year></pub-date><volume>23</volume><issue>4</issue><fpage>112</fpage><lpage>118</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Смирнова Н.Н., Галкина О.В., Новикова В.П., Прокопьева Н.Э., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Смирнова Н.Н., Галкина О.В., Новикова В.П., Прокопьева Н.Э.</copyright-holder><copyright-holder xml:lang="en">Smirnowa N.N., Galkina O.V., Novikova V.P., Prokopyeva N.E.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephrolog.ru/jour/article/view/1729">https://journal.nephrolog.ru/jour/article/view/1729</self-uri><abstract><p>Острое повреждение почек (ОПП) в отличие от острой почечной недостаточности является более широким понятием. Даже незначительные изменения экскреторной функции почек оказывают существенное влияние на работу всего организма. Возникновение ОПП увеличивает риск летального исхода, сроки госпитализации и стоимость лечения любой патологии. Цель данного обзора литературы - проанализировать возможности использования ряда маркеров в ранней диагностике различных вариантов ОПП в педиатрии. В обзор включены наиболее изученные и применимые в педиатрической практике маркеры: интерлейкин-18, липокалин, ассоциированный с желатиназой нейтрофилов (NGAL), молекула повреждения почек-1 (kim-1), цистатин С.</p></abstract><trans-abstract xml:lang="en"><p>Acute kidney injury (AKI), in contrast to acute renal failure, is a broader concept. Even minor changes in the excretory function of the kidneys have a significant impact on the work of the whole organism. The occurrence of AKI increases the risk of death, the length of hospitalization and the cost of treating any pathology. The purpose of this literature review is to analyze the possibilities of using a number of markers in the early diagnosis of various types of AKI in pediatrics. The review includes the most studied and applicable markers in pediatric practice - interleukin-18, Neutrophil Gelatinase-Associated Lipocalin (NGAL), kidney damage molecule-1 (KIM-1), cystatin C.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>интерлейкин-18</kwd><kwd>липокалин</kwd><kwd>ассоциированный с желатиназой нейтрофилов (NGAL)</kwd><kwd>молекула повреждения почек (kim-1)</kwd><kwd>острое повреждение почек</kwd><kwd>цистатин С</kwd></kwd-group><kwd-group xml:lang="en"><kwd>acute renal injury</kwd><kwd>biomarker</kwd><kwd>interleukin-18</kwd><kwd>kidney injury molecule-1 (KIM-1)</kwd><kwd>cystatin C</kwd><kwd>neutrophil gelatinase-associated lipocalin (NGAL)</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Пролетов ЯЮ, Саганова ЕС, Смирнов АВ. Биомаркеры в диагностике острого повреждения почек Сообщение 1. Нефрология 2014;18(4):25-32</mixed-citation><mixed-citation xml:lang="en">Proletov IaIu, Saganova ES, Smirnov AV. Biomarkery' v diagnostike ostrogo povrezhdeniia pochek Soobshchenie 1. Nephrology (Saint-Petersburg) 2014; 18(4): 25-32 (In Rus.)</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Devarajan P Update on mechanisms of ischemic acute kidney injury. JAm Soc Nephrol 2016;17(6):1503-1520</mixed-citation><mixed-citation xml:lang="en">Devarajan P Update on mechanisms of ischemic acute kidney injury. JAm Soc Nephrol 2016;17(6):1503-1520</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Гурина ОП, Дементьева ЕА, Блинов АЕ и др. Иммунофенотип лимфоцитов при вирус-ассоциированном гломерулонефрите у детей. В сборнике «Современная педиатрия», Санкт-Петербург - Белые ночи - 2018. Материалы форума. 2018. С. 38-39</mixed-citation><mixed-citation xml:lang="en">Gurina OP, Dement'eva EA, Blinov AE et al. Immunofenotip limfotcitov pri virus-assotciirovannom glomerulonefrite u detei'. V sbornike «Sovremennaia pediatriia», Sankt-Peterburg - Bely'e nochi - 2018 Materialy' foruma. 2018. S. 38-39</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Haase-Fielitz A, Bellomo R, Devarajan P The predictive performance of plasma neutrophil gelatinase associated lipocalin (NGAL) increases with grade of acute kidney injury. Nephrol Dialysis Transplant 2009;24(11):3349-3354</mixed-citation><mixed-citation xml:lang="en">Haase-Fielitz A, Bellomo R, Devarajan P The predictive performance of plasma neutrophil gelatinase associated lipocalin (NGAL) increases with grade of acute kidney injury. Nephrol Dialysis Transplant 2009;24(11):3349-3354</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Herget Rosenthal S, Marggraf G, Husing J. Early detection of acute renal failure by serum cystatin C. Kidney Int 2014;66(3): 1115-1122</mixed-citation><mixed-citation xml:lang="en">Herget Rosenthal S, Marggraf G, Husing J. Early detection of acute renal failure by serum cystatin C. Kidney Int 2014;66(3): 1115-1122</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Hilde R.H. de Geus, Michiel G. Betjes, Jan Bakker. Biomarkers for the prediction of acute kidney injury: a narrative review on current status and future challenges. Clin Kidney J 2012;5(2):102-108</mixed-citation><mixed-citation xml:lang="en">Hilde R.H. de Geus, Michiel G. Betjes, Jan Bakker. Biomarkers for the prediction of acute kidney injury: a narrative review on current status and future challenges. Clin Kidney J 2012;5(2):102-108</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Grigoryev DN, Liu M, Hassoun HT. The local and systemic inflammatory transcriptome after acute kidney injury. J Am Soc Nephrol 2008;19(3):547-558</mixed-citation><mixed-citation xml:lang="en">Grigoryev DN, Liu M, Hassoun HT. The local and systemic inflammatory transcriptome after acute kidney injury. J Am Soc Nephrol 2008;19(3):547-558</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Devarajan P Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of kidney disease. Scand J Clin Lab Invest 2008;68(2):89-94</mixed-citation><mixed-citation xml:lang="en">Devarajan P Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of kidney disease. Scand J Clin Lab Invest 2008;68(2):89-94</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Hollmen ME, Kyllonen LE, Inkinen KA et al. Urine neutrophil gelatinase-associated lipocalin is a marker of graft recovery after kidney transplantation. Kidney Int 2011;79 (4):89-98</mixed-citation><mixed-citation xml:lang="en">Hollmen ME, Kyllonen LE, Inkinen KA et al. Urine neutrophil gelatinase-associated lipocalin is a marker of graft recovery after kidney transplantation. Kidney Int 2011;79 (4):89-98</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Harpur E, Ennulat D, Hoffman D. Biological Qualification of Biomarkers of Chemical-Induced Renal Toxicity in Two Strains of Male Rat. Toxicol Sci 2011;122 (2):235-252</mixed-citation><mixed-citation xml:lang="en">Harpur E, Ennulat D, Hoffman D. Biological Qualification of Biomarkers of Chemical-Induced Renal Toxicity in Two Strains of Male Rat. Toxicol Sci 2011;122 (2):235-252</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Ferguson MA, Vaidya VS, Waikar SS et al. Urinary livertype fatty acid-binding protein predicts adverse outcomes in acute kidney injury. Kidney Int 2010;77:708-714</mixed-citation><mixed-citation xml:lang="en">Ferguson MA, Vaidya VS, Waikar SS et al. Urinary livertype fatty acid-binding protein predicts adverse outcomes in acute kidney injury. Kidney Int 2010;77:708-714</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Nakamura T, Sugaya T, Koide H. Urinary liver type fatty acid binding protein in septic shock: effect of polymyxin B immobilized fiber hemoperfusion. Shock 2009; 31(5):454-459</mixed-citation><mixed-citation xml:lang="en">Nakamura T, Sugaya T, Koide H. Urinary liver type fatty acid binding protein in septic shock: effect of polymyxin B immobilized fiber hemoperfusion. Shock 2009; 31(5):454-459</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Driver TH, Katz R, Ix JH et al. Urinary kidney injury molecule 1 (KIM-1) and interleukin 18 (IL-18) as risk markers for heart failure in older adults: the Health, Aging, and Body Composition (Health ABC) Study. Am J Kidney Dis 2014;64(1):49-56. doi:10.1053/j.ajkd.2014.01.432</mixed-citation><mixed-citation xml:lang="en">Driver TH, Katz R, Ix JH et al. Urinary kidney injury molecule 1 (KIM-1) and interleukin 18 (IL-18) as risk markers for heart failure in older adults: the Health, Aging, and Body Composition (Health ABC) Study. Am J Kidney Dis 2014;64(1):49-56. doi:10.1053/j.ajkd.2014.01.432</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">KDIGO. Clinical Practice Guideline for acute kidney injury. Kidney International Supplements 2012;2,2. doi:10.1038/kisup.2012.2</mixed-citation><mixed-citation xml:lang="en">KDIGO. Clinical Practice Guideline for acute kidney injury. Kidney International Supplements 2012;2,2. doi:10.1038/kisup.2012.2</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Ronco C, McCullough P, Anker SD et al. Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart J 2010;31(6):703-711. doi:10.1093/eurheartj/ehp507</mixed-citation><mixed-citation xml:lang="en">Ronco C, McCullough P, Anker SD et al. Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart J 2010;31(6):703-711. doi:10.1093/eurheartj/ehp507</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Cruz DN, Schmidt-Ott KM, Vescovo G et al. Pathophysiology of cardiorenal syndrome type 2 in stable chronic heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol 2013;182:117-136. doi: 10.1159/000349968.</mixed-citation><mixed-citation xml:lang="en">Cruz DN, Schmidt-Ott KM, Vescovo G et al. Pathophysiology of cardiorenal syndrome type 2 in stable chronic heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol 2013;182:117-136. doi: 10.1159/000349968.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Hu MC. Klotho and phosphate are modulators of pathologic uremic cardiac remodeling. J Am Soc Nephrol 2015;26(6):1290-1302. doi: 10.1681/ASN.2014050465</mixed-citation><mixed-citation xml:lang="en">Hu MC. Klotho and phosphate are modulators of pathologic uremic cardiac remodeling. J Am Soc Nephrol 2015;26(6):1290-1302. doi: 10.1681/ASN.2014050465</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Добронравов ВА. Фосфат, почки, кости и сердечнососудистая система. Нефрология 2016; 20(4):10-24</mixed-citation><mixed-citation xml:lang="en">Dobronravov VA. Fosfat, pochki, kosti i serdechnososudistaia sistema. Nephrology (Saint-Petersburg) 2016; 20(4):10-24 (In Rus.)</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Shin IS, Shin HK, Kim JC, Lee MY Role of Klotho, an antiaging protein, in pulmonary fibrosis. Arch Toxicol 2015;89(5):785-795. doi: 10.1007/s00204-014-1282-y</mixed-citation><mixed-citation xml:lang="en">Shin IS, Shin HK, Kim JC, Lee MY Role of Klotho, an antiaging protein, in pulmonary fibrosis. Arch Toxicol 2015;89(5):785-795. doi: 10.1007/s00204-014-1282-y</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Romundstad S, Naustdal T, Romundstad PR et al. COPD and microalbuminuria: a 12-year follow-up study. Eur Respir J 2014;43(4):1042-1050. doi: 10.1183/09031936.00160213</mixed-citation><mixed-citation xml:lang="en">Romundstad S, Naustdal T, Romundstad PR et al. COPD and microalbuminuria: a 12-year follow-up study. Eur Respir J 2014;43(4):1042-1050. doi: 10.1183/09031936.00160213</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Katz DH, Burns JA, Aguilar FGet al. Albuminuria is independently associated with cardiac remodeling, abnormal right and left ventricular function, and worse outcomes in heart failure with preserved ejection fraction. JACC Heart Fail 2014;2(6):586-596. doi:10.1016/j.jchf.2014.05.016</mixed-citation><mixed-citation xml:lang="en">Katz DH, Burns JA, Aguilar FGet al. Albuminuria is independently associated with cardiac remodeling, abnormal right and left ventricular function, and worse outcomes in heart failure with preserved ejection fraction. JACC Heart Fail 2014;2(6):586-596. doi:10.1016/j.jchf.2014.05.016</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Nicocia G, Buemi M. Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients. Kidney Blood Press Res 2009; 32 (1):91-98</mixed-citation><mixed-citation xml:lang="en">Nicocia G, Buemi M. Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients. Kidney Blood Press Res 2009; 32 (1):91-98</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Bolignano D, Lacquaniti A, Coppolino G et al. Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients. Kidney Blood Press Res 2009; 32 (1):91-98</mixed-citation><mixed-citation xml:lang="en">Bolignano D, Lacquaniti A, Coppolino G et al. Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients. Kidney Blood Press Res 2009; 32 (1):91-98</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Doi K, Noiri E, Sugaya T. Urinary L-type fatty acid-binding protein as a new enal biomarker in critical care. Curr Opin Crit Care 2010; 16 (6): 545-549</mixed-citation><mixed-citation xml:lang="en">Doi  K, Noiri E, Sugaya T. Urinary L-type fatty acid-binding protein as a new renal biomarker in critical care. Curr Opin Crit Care 2010; 16 (6): 545-549</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Parikh CR, Mishra J, Thiessen-Philbrook H et al. Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int 2006; 70: 199-203</mixed-citation><mixed-citation xml:lang="en">Parikh CR, Mishra J, Thiessen-Philbrook H et al. Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int 2006; 70: 199-203</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Trang K. Huynh, David A Bateman, Elvira Parravicini et al. Reference Values of Urinary Neutrophil Gelatinase-Associated Lipocalin in Very Low Birth Weight Infants. Pediatr Res2009 November; 66(5): 528-532. doi:10.1203/PDR.0b013e3181baa3dd)</mixed-citation><mixed-citation xml:lang="en">Trang K. Huynh, David A Bateman, Elvira Parravicini et al. Reference Values of Urinary Neutrophil Gelatinase-Associated Lipocalin in Very Low Birth Weight Infants. Pediatr Res2009 November; 66(5): 528-532. doi:10.1203/PDR.0b013e3181baa3dd)</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Ek-Von Mentzer BA, Zhang F, Hamilton JA. Binding of 13-HODE and 15-HETE to phospholipid bilayers, albumin, and intracellular fatty acid binding proteins. implications for transmembrane and intracellular transport and for protection from lipid peroxidation. J Biol Chem 2014; 276(19): 15575-15580</mixed-citation><mixed-citation xml:lang="en">Ek-Von Mentzer BA, Zhang F, Hamilton JA. Binding of 13-HODE and 15-HETE to phospholipid bilayers, albumin, and intracellular fatty acid binding proteins. implications for transmembrane and intracellular transport and for protection from lipid peroxidation. J Biol Chem 2014; 276(19): 15575-15580</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Geus H, Betjes M, Bakker J. Biomarkers for the prediction of acute kidney injury: a narrative review on current status and future challenges. Clin Kidney J 2012; 5(2): 102-108</mixed-citation><mixed-citation xml:lang="en">Geus H, Betjes M, Bakker J. Biomarkers for the prediction of acute kidney injury: a narrative review on current status and future challenges. Clin Kidney J 2012; 5(2): 102-108</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Haase M, Bellomo R, Devarajan P et al. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and metaanalysis. Am J Kidney Dis 2009; 54 (4):1012-1024</mixed-citation><mixed-citation xml:lang="en">Haase M, Bellomo R, Devarajan P et al. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and metaanalysis. Am J Kidney Dis 2009; 54 (4):1012-1024</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Brunner HI, Mueller M, Rutherford C et al. Urinary neutrophil gelatinase-associated lipocalin as a biomarker of nephritis in childhood-onset systemic lupus erythematosus. Arthritis Rheum 2006; 54(2): 2577-2584</mixed-citation><mixed-citation xml:lang="en">Brunner HI, Mueller M, Rutherford C et al. Urinary neutrophil gelatinase-associated lipocalin as a biomarker of nephritis in childhood-onset systemic lupus erythematosus. Arthritis Rheum 2006; 54(2): 2577-2584</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Parikh CR, Jani A, Mishra J et al. Urine NGAL and IL-18 are predictive bio-markers for delayed graft function following kidney transplantation. Am J Transplant 2006; 6(1): 1639-1645</mixed-citation><mixed-citation xml:lang="en">Parikh CR, Jani A, Mishra J et al. Urine NGAL and IL-18 are predictive bio-markers for delayed graft function following kidney transplantation. Am J Transplant 2006; 6(1): 1639-1645</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Mori K, Lee HT, Rapoport D. Endocytic delivery of lipo-calin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 2005; 115 (3): 610-621</mixed-citation><mixed-citation xml:lang="en">Mori K, Lee HT, Rapoport D. Endocytic delivery of lipo-calin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 2005; 115 (3): 610-621</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Nejat M, Hill JV, Pickering J. Albuminuria increases cys-tatin C excretion: implications for urinary biomarkers. Nephrol Dial Transplan 2011; 26 (5): 1553-1558</mixed-citation><mixed-citation xml:lang="en">Nejat M, Hill JV, Pickering J. Albuminuria increases cys-tatin C excretion: implications for urinary biomarkers. Nephrol Dial Transplan 2011; 26 (5): 1553-1558</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Portilla D, Dent C, Sugaya T et al. Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery. Kidney Int. 2007; 73:465-472</mixed-citation><mixed-citation xml:lang="en">Portilla D, Dent C, Sugaya T et al. Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery. Kidney Int. 2007; 73:465-472</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Schmidt Ott KM, Mori K, Li JY Dual action of neutrophil gelatinase associated lipocalin. J Am Soc Nephrol 2007;18 (2): 407-413</mixed-citation><mixed-citation xml:lang="en">Schmidt Ott KM, Mori K, Li JY Dual action of neutrophil gelatinase associated lipocalin. J Am Soc Nephrol 2007;18 (2): 407-413</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Liang XL, Liu SX, Chen YH. Combination of urinary kidney injury molecule-1 and interleukin-18 as early biomarker for the diagnosis and progressive assessment of acute kidney injury following cardiopulmonary bypass surgery: a prospective. Biomarkers 2010; 15 (4): 332-339</mixed-citation><mixed-citation xml:lang="en">Liang XL, Liu SX, Chen YH. Combination of urinary kidney injury molecule-1 and interleukin-18 as early biomarker for the diagnosis and progressive assessment of acute kidney injury following cardiopulmonary bypass surgery: a prospective. Biomarkers 2010; 15 (4): 332-339</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Matsui K, Kamijo-Ikemori A, Hara M. Clinical significance of tubular and podocyte biomarkers in acute kidney injury. Clin Exp Nephrol 2011; 15 (2): 220-225</mixed-citation><mixed-citation xml:lang="en">Matsui K, Kamijo-Ikemori A, Hara M. Clinical significance of tubular and podocyte biomarkers in acute kidney injury. Clin Exp Nephrol 2011; 15 (2): 220-225</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Negishi K, Noiri E, Doi K. Monitoring of urinary L-type fatty acid-binding protein predicts histological severity of acute kidney injury. Am J Pathol 2009; 174 (4): 1154-1159</mixed-citation><mixed-citation xml:lang="en">Negishi K, Noiri E, Doi  K. Monitoring of urinary L-type fatty acid-binding protein predicts histological severity of acute kidney injury. Am J Pathol 2009; 174 (4): 1154-1159</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Nickolas TL, O’Rourke MJ, Yang J. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase associated lipocalin for diagnosing acute kidney injury. Ann Intern Med 2008; 148 (11): 810-819</mixed-citation><mixed-citation xml:lang="en">Nickolas TL, O’Rourke MJ, Yang J. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase associated lipocalin for diagnosing acute kidney injury. Ann Intern Med 2008; 148 (11): 810-819</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Endre ZH, Pickering JW, Walker RJ. Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function. Kidney Int 2011; 79 (10): 1119-1130</mixed-citation><mixed-citation xml:lang="en">Endre ZH, Pickering JW, Walker RJ. Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function. Kidney Int 2011; 79 (10): 1119-1130</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Wang Z, Ji Y Wang S, Wang R. Protective effect of intestinal ischemic preconditioning on ischemia reperfusion-caused lung injury in rats. Inflammation 2015; 38(3): 424-432</mixed-citation><mixed-citation xml:lang="en">Wang Z, Ji Y Wang S, Wang R. Protective effect of intestinal ischemic preconditioning on ischemia reperfusion-caused lung injury in rats. Inflammation 2015; 38(3): 424-432</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Mishra J, Dent C, Tarabishi R et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005; 365:1231-1238</mixed-citation><mixed-citation xml:lang="en">Mishra J, Dent C, Tarabishi R et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005; 365:1231-1238</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Goetz DH, Holmes MA, Borregaard N et al. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with sidero-phore-mediated iron acquisition. Mol Cell 2012; 10 (5):1033-1043</mixed-citation><mixed-citation xml:lang="en">Goetz DH, Holmes MA, Borregaard N et al. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with sidero-phore-mediated iron acquisition. Mol Cell 2012; 10 (5):1033-1043</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Arambasic J, Mandic S, Debeljak Z et al. Differentiation of acute pyelonephritis from other febrile states in children using urinary neutrophil gelatinase-associated lipocalin (uNGAL). Clin Chem Lab Med 2016 Jan; 54(1):55-61. doi: 10.1515/cclm-2015-0377</mixed-citation><mixed-citation xml:lang="en">Arambasic J, Mandic S, Debeljak Z et al. Differentiation of acute pyelonephritis from other febrile states in children using urinary neutrophil gelatinase-associated lipocalin (uNGAL). Clin Chem Lab Med 2016 Jan; 54(1):55-61. doi: 10.1515/cclm-2015-0377</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Ichimura T, Hung CC, Yang SA. Kidney injury molecule1: a tissue and urinary biomarker for nephrotoxicant induced renal injury. Am J Physiol 2004; 286 (3): 552-563</mixed-citation><mixed-citation xml:lang="en">Ichimura T, Hung CC, Yang SA. Kidney injury molecule1: a tissue and urinary biomarker for nephrotoxicant induced renal injury. Am J Physiol 2004; 286 (3): 552-563</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Devarajan P Neutrophil gelatinase-associated lipocalin: new paths for an old shuttle. Cancer Ther 2007; 5 (B): 463-470</mixed-citation><mixed-citation xml:lang="en">Devarajan P Neutrophil gelatinase-associated lipocalin: new paths for an old shuttle. Cancer Ther 2007; 5 (B): 463-470</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Stevens LA, Levey AS. Measurement of kidney function. Med Clin North Am 2015; 89 (3): 457-473</mixed-citation><mixed-citation xml:lang="en">Stevens LA, Levey AS. Measurement of kidney function. Med Clin North Am 2015; 89 (3): 457-473</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Supavekin S, Zhang W, Kucherlapati R. Differential gene expression following early renal ischemia/reperfusion. Kidney Int 2003; 63 (5): 1714-1724</mixed-citation><mixed-citation xml:lang="en">Supavekin S, Zhang W, Kucherlapati R. Differential gene expression following early renal ischemia/reperfusion. Kidney Int 2003; 63 (5): 1714-1724</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Siew ED, Ikizler TA, Gebretsadik T. Elevated urinary IL-18 levels at the time of ICU admission predict adverse clinical outcomes. Clin J Am Soc Nephrol 2010; 5 (8): 1497-150</mixed-citation><mixed-citation xml:lang="en">Siew ED, Ikizler TA, Gebretsadik T. Elevated urinary IL-18 levels at the time of ICU admission predict adverse clinical outcomes. Clin J Am Soc Nephrol 2010; 5 (8): 1497-150</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Uchino S, Doig GS, Bellomo R. Diuretics and mortality in acute renal failure. Crit Care Med 2004; 32 (5):1669-1677</mixed-citation><mixed-citation xml:lang="en">Uchino S, Doig GS, Bellomo R. Diuretics and mortality in acute renal failure. Crit Care Med 2004; 32 (5):1669-1677</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Bennett MR, Nehus E, Haffner Ch et al. Pediatric reference ranges for acute kidney injury biomarkers. Pediatr Nephrol 2015; 30(4): 677-685</mixed-citation><mixed-citation xml:lang="en">Bennett MR, Nehus E, Haffner Ch et al. Pediatric reference ranges for acute kidney injury biomarkers. Pediatr Nephrol 2015; 30(4): 677-685</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
